TONI PLUMMER: Open Payments
NPI 1780166249 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,397 in 103 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $96 · 2025 $2,397
Food & beverage: $2,397
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $629 |
| Axsome Therapeutics, Inc. | 13 | $346 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $248 |
| Neurocrine BioSciences, Inc. | 5 | $214 |
| Teva Pharmaceuticals USA, Inc. | 9 | $181 |
| Vanda Pharmaceuticals Inc. | 7 | $178 |
| Supernus Pharmaceuticals, Inc. | 8 | $142 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| Alkermes, Inc. | 5 | $99 |
| Validus Pharmaceuticals LLC | 3 | $62 |
Products named: VRAYLAR, Auvelity, CAPLYTA, INGREZZA, AUSTEDO XR, REXULTI, FANAPT, Qelbree.
Industry payments across VA — which companies pay providers there.
